Reilly T M, Flint S K, McHugh B G, Wilsbach-Volcheck K M, Timmermans P B
E.I. du Pont de Nemours and Company, Inc., Medical Products Department, Wilmington, DE 19898.
Hybridoma. 1988 Apr;7(2):177-84. doi: 10.1089/hyb.1988.7.177.
Five murine monoclonal antibodies have been produced against the 1-chain form of human tissue plasminogen activator (t-PA). Affinity constants, calculated from data generated in a solid phase radioimmunoassay, ranged from 4.9 x 10(8)M-1 to 2.3 x 10(9) M-1 for these antibodies. This panel was classified into three groups based on the antibodies' effects on both the plasminogen activation and amidolytic activities of t-PA: complete inhibitors (CD2), partial inhibitors (DB10), and those with limited effects (AE5, BA10 and EG2). This same pattern for the five antibodies was observed in an assay measuring the binding of 125I-t-PA to its fast-acting inhibitor, PAI-1. It is concluded that this panel of antibodies defines at least three domains on the t-PA molecule, including its catalytic site.
已制备出五种针对人组织纤溶酶原激活剂(t-PA)的1链形式的鼠单克隆抗体。通过固相放射免疫分析所产生的数据计算出,这些抗体的亲和常数范围为4.9×10⁸M⁻¹至2.3×10⁹M⁻¹。根据这些抗体对t-PA的纤溶酶原激活活性和酰胺水解活性的影响,该组抗体被分为三组:完全抑制剂(CD2)、部分抑制剂(DB10)以及影响有限的抗体(AE5、BA10和EG2)。在测量¹²⁵I-t-PA与其快速作用抑制剂PAI-1结合的分析中,观察到这五种抗体呈现相同模式。得出的结论是,该组抗体确定了t-PA分子上至少三个结构域,包括其催化位点。